Newswise — Princeton, NJ—February 29, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its candidates today for open positions on the 2016–2017 Board of Directors. The Board of Directors drives ISPOR's strategic direction and is responsible for the management of the Society, including its committees, publications, budget and governance. The Board is the policy making body of the Society.
The positions and candidates for the 2016–2017 ISPOR Board of Directors include:
President-Elect Newell McElwee, PharmD, MSPHAssociate Vice President, Merck (North Wales, PA, USA) Shelby D. Reed, PhD, RPhProfessor, Duke University (Durham, NC, USA)
Director Mirjana Huic, MD, MSc, PhDAssistant Director, Croatia Agency for Quality and Accreditation in Health Care and Social Work (Zagreb, Croatia) Joanna Lis, PhD, MSc, MBADirector of Market Access, Sanofi-Aventis (Warsaw, Poland)
Director Brian Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences (Irvine, CA, USA) John Watkins, PharmD, MPHFormulary Manager, Premera Blue Cross (Mountlake Terrace, WA, USA)
Director Nathorn Chaiyakunapruk, PharmD, PhDProfessor, School of Pharmacy, Monash University (Selangor, Malaysia) Gordon Liu, PhDProfessor of Economics, Peking University, National School of Development (Bejing, China)
Director Rosanna Tarricone, PhD, MScAssociate Professor, Bocconi University (Milan, Italy) Mondher Toumi, MD, MSc, PhDProfessor, University Aix-Marseille (Paris, France)
ISPOR members will be invited to vote beginning March 1 with elections closing on May 1, 2016. Information on each of the candidates–including biographies and vision statements–can be found on the ISPOR Board of Directors Elections webpage. Only ISPOR global members are eligible to vote in the elections. Information about the Society and the benefits of membership can be found here.
ABOUT ISPORThe International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ISPOR.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT |Facebook: http://bit.ly/ISPOR-FB
RSS